BIOMAT Database Logo BIOMAT Database Logo

Chemoimmunotherapy for Triple-Negative Breast Cancer. 2018

Anita Slomski

UI MeSH Term Description Entries

Related Publications

Anita Slomski
Nanoparticles for Chemoimmunotherapy Against Triple-Negative Breast Cancer.
January 2022, International journal of nanomedicine,
Anita Slomski
Mise en place: toward neoadjuvant chemoimmunotherapy for early triple-negative breast cancer.
May 2020, Annals of oncology : official journal of the European Society for Medical Oncology,
Anita Slomski
Macrophage-camouflaged epigenetic nanoinducers enhance chemoimmunotherapy in triple negative breast cancer.
October 2023, Acta pharmaceutica Sinica. B,
Anita Slomski
Adenosine-modulating synthetic high-density lipoprotein for chemoimmunotherapy of triple-negative breast cancer.
March 2024, Journal of controlled release : official journal of the Controlled Release Society,
Anita Slomski
Doxorubicin-Loaded Platelet Decoys for Enhanced Chemoimmunotherapy Against Triple-Negative Breast Cancer in Mice Model.
January 2023, International journal of nanomedicine,
Anita Slomski
Pathological Complete Response to Neoadjuvant Chemoimmunotherapy for Early Triple-Negative Breast Cancer: An Updated Meta-Analysis.
June 2022, Cells,
Anita Slomski
Neoadjuvant chemoimmunotherapy in early triple-negative breast cancer: a new kid on the block?
July 2022, Immunotherapy,
Anita Slomski
Immunologic Factors Associated with Differential Response to Neoadjuvant Chemoimmunotherapy in Triple-Negative Breast Cancer.
April 2024, Journal of personalized medicine,
Anita Slomski
Immunotherapy for Triple-Negative Breast Cancer.
November 2021, Pharmaceutics,
Anita Slomski
Theranostics for Triple-Negative Breast Cancer.
January 2023, Diagnostics (Basel, Switzerland),
Copied contents to your clipboard!